Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma.

Keller, Brian; Bruynzeel, Anna M E; Tang, Chad; Swaminath, Anand; Kerkmeijer, Linda; Chu, William

Keller, Brian; Bruynzeel, Anna M E; Tang, Chad; Swaminath, Anand; Kerkmeijer, Linda; Chu, William.

Afiliación

Keller B; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Bruynzeel AME; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Swaminath A; Department of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
Kerkmeijer L; Department of Radiation Oncology, Radboudumc, Nijmegen, Netherlands.
Chu W; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Front Oncol ; 11: 634830, 2021.

Article en En | MEDLINE | ID: mdl-34046341

Palabras clave

MR-guided radiotherapy; MR-linac; image-guided radiotherapy; renal cell carcinoma; stereotactic body radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google